TableĀ 2

Overall ratings of AGREE II items

DomainItems in domainOverall rating of each item given as mean (SD). Scores could range from 1 to 7
ItemDomain
Scope and purposeThe overall objective(s) of the guideline is (are) specifically described5.6 (1.6)5.7 (1.4)
The health question(s) covered by the guideline is (are) specifically described5.7 (1.4)
The population (patients, public etc.) to which the guideline is meant to apply is specifically described5.8 (1.3)
Stakeholder involvementThe guideline development group includes individuals from all relevant professional groups5.3 (1.5)4.8 (2.0)
The views and preferences of the target population (patients, public, etc.) have been sought3.3 (2.1)
The target users of the guideline are clearly defined5.9 (1.2)
Rigour of developmentSystematic methods were used to search for evidence4.5 (2.1)4.8 (2.0)
The criteria for selecting the evidence are clearly described4.5 (2.2)
The strengths and limitations of the body of evidence are clearly described4.1 (2.0)
The methods for formulating the recommendations are clearly described5.4 (1.4)
The health benefits, side effects and risks have been considered in formulating the recommendations5.1 (1.8)
There is an explicit link between the recommendations and the supporting evidence5.2 (1.6)
The guideline has been externally reviewed by experts prior to its publication4.0 (2.3)
A procedure for updating the guideline is provided5.7 (1.8)
Clarity of presentationThe recommendations are specific and unambiguous5.7 (1.2)5.7 (1.3)
The different options for management of the condition or health issue are clearly presented5.5 (1.5)
Key recommendations are easily identifiable5.8 (1.4)
ApplicabilityThe guideline describes the facilitators and barriers to its application4.3 (1.8)4.3 (1.9)
The guideline provides advice and/or tools on how the recommendation can be put into practice5.3 (1.3)
The potential resource implications of applying the recommendations have been considered3.7 (2.1)
The guideline presents the monitoring and/or auditing criteria3.8 (1.9)
Editorial independenceThe views of the funding body have not influenced the content of the guideline5.4 (1.8)5.6 (1.6)
Competing interests of the guideline development group members have been recorded and addressed5.9 (1.4)